Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 387

    Roche says FDA grants priority review to hemophilia drug emicizumab

    Roche says FDA grants priority review to hemophilia drug emicizumab

    Ruby Khatun Khatun25 Aug 2017 10:00 AM IST
    ZURICH: Swiss pharma group Roche said the U.S. Food and Drug Administration (FDA) granted priority review to its emicizumab for hemophilia A with...
    Fujifilm aims to double revenues in India by 2020

    Fujifilm aims to double revenues in India by 2020

    Ruby Khatun Khatun25 Aug 2017 9:30 AM IST
    Chennai: Fujifilm India, a wholly owned subsidiary of Japan-based Fujifilm Holdings Corporation, is aiming to more than double revenues by 2020, on...
    Dr Reddys out-licenses steroid DFD-06 to Encore Dermatology

    Dr Reddys out-licenses steroid DFD-06 to Encore Dermatology

    Ruby Khatun Khatun24 Aug 2017 11:00 AM IST
    New Delhi: Drug major Dr Reddy's Laboratories on Tuesday said it has out-licensed the future development, manufacturing and commercialisation rights...
    Zydus Cadila gets final USFDA nod for Pindolol tablets

    Zydus Cadila gets final USFDA nod for Pindolol tablets

    Ruby Khatun Khatun24 Aug 2017 10:30 AM IST
    New Delhi: Drug firm Zydus Cadila on Tuesday said it has received final approval from the US health regulator to market Pindolol tablets, used for the...
    Eisai Pharma launches first-in-class epilepsy treatment Fycompa (Perampanel) in India

    Eisai Pharma launches first-in-class epilepsy treatment Fycompa (Perampanel) in India

    Ruby Khatun Khatun24 Aug 2017 10:00 AM IST
    Eisai Pharmaceuticals India Pvt. Ltd, a leading Japanese pharmaceutical company announced the launch of Fycompa (perampanel), a new anti-epileptic...
    Medtronic misses revenue estimates, shares dip

    Medtronic misses revenue estimates, shares dip

    Ruby Khatun Khatun24 Aug 2017 9:30 AM IST
    Medical device maker Medtronic Plc on Tuesday reported quarterly revenue fell short of analysts' estimates, hurt by lower sales in its...
    Shire CFO resigns to join plant technology start-up

    Shire CFO resigns to join plant technology start-up

    Ruby Khatun Khatun24 Aug 2017 9:00 AM IST
    LONDON: Pharmaceutical company Shire said its chief financial officer Jeff Poulton will stand down at the end of the year to join Indigo Ag, a...
    Massive California verdict expands Johnson and Johnsons talc battlefield

    Massive California verdict expands Johnson and Johnsons talc battlefield

    Ruby Khatun Khatun23 Aug 2017 11:00 AM IST
    NEW YORK: A massive California verdict in a lawsuit alleging Johnson and Johnson's talc-based products cause cancer has opened a new front in the...
    Aurobindo Pharma gets USFDA nod for anti-HIV drug

    Aurobindo Pharma gets USFDA nod for anti-HIV drug

    Ruby Khatun Khatun23 Aug 2017 10:30 AM IST
    New Delhi: Aurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets,...
    Lupin gets EIR from USFDA for Aurangabad unit

    Lupin gets EIR from USFDA for Aurangabad unit

    Ruby Khatun Khatun23 Aug 2017 10:00 AM IST
    New Delhi: Drug firm Lupin said it has received establishment inspection report (EIR) from the US health regulator for its Aurangabad plant in...
    AstraZeneca ups investment in messenger RNA drugs with Ethris deal

    AstraZeneca ups investment in messenger RNA drugs with Ethris deal

    Ruby Khatun Khatun23 Aug 2017 9:30 AM IST
    FRANKFURT: AstraZeneca has stepped up its investment in messenger RNA drugs, a promising approach in genetic therapy, by spending more than 25 million...
    Suven Life secures product patent in Japan

    Suven Life secures product patent in Japan

    Ruby Khatun Khatun22 Aug 2017 10:30 AM IST
    New Delhi: Suven Life Sciences on Monday said it has secured a product patent in Japan to be used for developing therapeutic agents that are useful in...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Only doctor can decide line of treatment of a patient, NOT insurance company: Consumer Court

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok